E-400

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of E-400

Quick Facts: E-400 Identity

Property Description
Active ingredient Alpha-Tocopherol (Vitamin E)
Form Softgel capsule, oil solution
Pharmacological class Fat-soluble vitamin, Antioxidant
Common purpose Essential nutritional support
Origin Exogenous (natural or synthetic)

What is E-400 and What is its Composition?

E-400 is a nutritional supplement and vitamin preparation whose active ingredient is alpha-Tocopherol, which is the primary form of Vitamin E utilized by the body. The dosage strength, designated as 400 IU (International Units), reflects the measured biological activity of the contained alpha-Tocopherol compound, typically presented as a non-prescription (OTC) preparation.


As an essential nutrient, Vitamin E must be obtained from an exogenous source, meaning the body requires it but cannot synthesize it, necessitating intake from diet or supplementation. This alpha-Tocopherol is a lipophilic (fat-soluble) compound, which is why E-400 is typically presented as a Softgel capsule containing the active ingredient dissolved in an oil solution. This preparation is designed to optimize stability and absorption after oral administration of this single-active-ingredient product.


E-400's Classification: A Fat-Soluble Antioxidant

E-400 belongs to the pharmacological class of fat-soluble vitamins and functions primarily as an Antioxidant. The physiological action involves it acting as a free radical scavenger in the body, neutralizing unstable molecules known as free radicals.


The Antioxidant role involves its ability to protect critical cellular structures, such as cell membranes, from damage. E-400 embeds itself directly into the lipid bilayer of cell membranes, where it readily prevents lipid peroxidation, a process that would otherwise compromise the physical integrity of the cell. This protective mechanism is fundamental to sustaining normal physiological function across tissues susceptible to oxidative stress, such as those involved in maintaining cardiovascular health.


Is E-400 Natural or Synthetic, and What is its General Purpose?

The alpha-Tocopherol in E-400 may be sourced either as the natural form (D-alpha-Tocopherol) or a synthetic form (DL-alpha-Tocopheryl acetate), a distinction often serving as a key differentiating factor in commercial offerings. The overarching purpose of E-400 is to provide supplementation that supports the body's natural defenses and ensures adequate levels of this essential dietary component are available for maintaining cellular stability and function.

What side effects are possible with E-400?

Possible side effects and safety information

The safety profile of E-400 (Alpha-Tocopherol) is defined by officially documented adverse reactions and safety considerations, classified according to regulatory standards by government health authorities.


Officially Documented Adverse Reactions and Frequencies

The most commonly reported adverse effects associated with the oral intake of alpha-Tocopherol, particularly at higher doses, primarily involve the Gastrointestinal and Nervous systems.

  • Common Adverse Reactions: Effects classified as common in official regulatory documents include nausea, diarrhea, abdominal cramps, and general gastrointestinal discomfort. Headache and fatigue are also listed as common occurrences, aligning with the Nervous system disorders class.
  • Uncommon Reactions: Less frequently reported effects may include visual disturbances, pruritus, and rash.

Documented Serious Adverse Reactions and Risk Factors

Safety information explicitly documents that consumption of high doses of E-400 is associated with a specific, serious adverse reaction concerning the vascular system.

  • Increased Bleeding Risk: Official safety labeling highlights a link between high-dose alpha-Tocopherol and an increased risk of hemorrhage and potentially hemorrhagic stroke. This serious risk is primarily associated with long-term use at daily doses exceeding 800 IU.

Population-Specific Safety Considerations

Regulatory safety information includes specific cautions regarding interactions, which focus on individuals on other treatments affecting blood coagulation.

  • Interaction with Anticoagulants: Individuals concurrently using anticoagulant medicines (e.g., Warfarin) are identified as a special population for safety consideration. Alpha-Tocopherol has the documented potential to potentiate the effects of anticoagulants, which significantly increases the risk of bleeding. Patients with Vitamin K deficiency also carry an exacerbated hemorrhage risk.

Overdose and Emergency Response

Overdose and when to seek help for E-400 (Alpha-Tocopherol)

Official regulatory documentation classifies E-400 (Alpha-Tocopherol) as a substance with low acute toxicity, with overdose manifestations generally associated with the ingestion of very high doses over prolonged periods.

Overdose presentations most commonly include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain, alongside systemic effects like headache and fatigue.

Officially Documented Manifestations Regulator-Listed Severe Outcome
Nausea, Diarrhea, Abdominal pain Increased risk of hemorrhage (bleeding)
Fatigue, Weakness, Blurred vision Risk amplified by concurrent anticoagulant use

The most significant concern documented in official warnings is the increased risk of bleeding. This risk is specifically noted to be amplified in individuals simultaneously receiving oral anticoagulant therapy, making them a population requiring heightened consideration.

In all cases of suspected overdose, official regulatory information mandates that immediate medical attention must be sought. The documented management consists of symptomatic and supportive measures. The official prescribing information confirms that no specific antidote is known for Alpha-Tocopherol overdose. Hospital monitoring may be required, particularly when severe outcomes are suspected or in high-risk patients.

Therapeutic Uses of E-400

What E-400 Treats: Main Uses and Benefits

E-400 is commonly used in situations involving symptoms that create noticeable physiological strain. This supplement is considered relevant when supportive symptom management is appropriate and contributes to easing the overall symptom load. E-400 is applied across therapeutic domains where additional support is needed in the context of physiological stress.

The supplement is considered relevant in contexts marked by increased discomfort or tension, and is applied in scenarios where additional symptomatic support is needed. It is commonly used for managing condition categories presenting with acute episodes or those characterized by periods of heightened symptoms.


Key Areas of Symptom Support

E-400 is often used when individuals experience conditions characterized by periods of heightened symptoms where the primary goal is to provide support that helps ease the overall symptom burden. These supportive uses help address symptom clusters that may become intense or disruptive and interfere with daily functioning.

“It offers symptomatic relief that helps patients cope more steadily with symptom fluctuations during difficult episodes.”

Quick Fact: Support for Disruptive Symptoms

The supplement is applied in clinical settings that involve acute or unstable symptom patterns, and may assist with supporting functional stability during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus overview of Vitamin E

Eligibility and Restrictions for Use

The official regulatory profile for E-400 (Alpha-Tocopherol) defines specific population eligibility and non-eligibility rules, strictly based on government documentation.

Populations Allowed or Contraindicated

Contraindicated: Absolute prohibition applies to patients with known hypersensitivity to alpha-tocopherol or any of the product’s excipients.

Permitted: Use is generally acceptable for healthy adults for nutritional supplementation and for individuals with confirmed Vitamin E deficiency.


Eligibility Restrictions

High-dose E-400 (ge400 IU) is subject to several restrictions and cautions documented by regulatory authorities:

  • Pregnancy and Lactation: Use is not recommended when the dosage is above the Recommended Daily Allowance (RDA).
  • Coagulation Risk: Patients with bleeding disorders or Vitamin K deficiency must use with caution due to documented increased bleeding risk.
  • Surgical Patients: High-dose use must be discontinued one month prior to scheduled surgery.
  • Age- and Condition-Specific: Use in children for non-deficiency purposes requires specialized medical advice. Specific warnings apply to adults 55 years or older with heart disease or diabetes regarding uncontrolled high-dose intake.
  • Organ Function: Patients with renal impairment require an individualized dose assessment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify interactions with E-400 (Alpha-Tocopherol) into patterns of pharmacodynamic potentiation and pharmacokinetic interference. All interactions listed apply particularly to high-dose administration.

Drug-Drug Interactions

The most significant interaction involves pharmacodynamic potentiation with agents that affect blood clotting. High doses of E-400 may increase the risk of hemorrhage by potentiating the effects of anticoagulants, such as Warfarin, and antiplatelet agents, including Aspirin. This combination necessitates close monitoring of coagulation parameters, such as the International Normalized Ratio (INR), as detailed in official prescribing information.

E-400 may also enhance the side effects of certain drugs, including Amiodarone, Ciclosporin, and Zidovudine.

Exposure-Altering Interactions

Interactions resulting in reduced exposure to E-400 occur with substances that interfere with fat absorption. Orlistat, bile acid sequestrants (e.g., Colestyramine), and mineral oil may reduce the absorption of E-400, leading to lower plasma concentrations. Conversely, anticonvulsants (e.g., Phenobarbital) and oral contraceptives may also lower the plasma levels of Vitamin E.

To mitigate absorption interference, regulatory documents establish a timing rule mandating that E-400 must be administered at least two hours before or two hours after the administration of Orlistat.

Population-Specific Considerations

The bleeding risk associated with these interactions is documented as heightened in specific populations, including patients with existing Vitamin K deficiencies or a history of hemorrhagic stroke.

Mechanism of Action

The mechanism of Alpha-Tocopherol (E-400) is defined by its two primary actions: direct chemical defense and cellular signaling modulation.

Alpha-Tocopherol functions as a chain-breaking antioxidant by embedding itself within the lipid bilayer of cell membranes. Its structure allows it to neutralize peroxyl radicals and other Reactive Oxygen Species (ROS) through hydrogen atom donation, interrupting the lipid peroxidation pathway. This core chemical action contributes to the maintenance of the structural and functional characteristics of cell membranes and circulating lipoproteins.

E-400 also acts as a modulator of intracellular processes by inhibiting enzymes like Protein Kinase C (PKC) and suppressing the gene expression of adhesion molecules (such as ICAM-1). This modulation results in the decreasing adhesion of blood components to the vessel wall, contributing to the regulation of vascular dynamics and endothelial function.

The resulting physiological effects are confined by a mechanistic constraint: the Alpha-Tocopherol Transfer Protein (alpha-TTP) selectively retains only the alpha-form of the molecule. This mechanism governs the selective systemic retention, limiting the biological action to the specific effects mediated exclusively by Alpha-Tocopherol.

Dosage and Administration Information

Official Administration Guidelines for E-400 (Alpha-Tocopherol)

The proper use of Alpha-Tocopherol, such as the 400 IU softgel, is dictated by specific regulatory instructions concerning its administration and dosing limits. The primary route for this form is oral administration, although official documents also define administration via topical application and specialized parenteral injection for clinical uses. E-400 is typically employed as part of a long-term nutritional support plan.


Dosing Frequency and Limits

The standard administration frequency for supplemental use is once daily. Regulatory guidance establishes the Tolerable Upper Intake Level (UL) for adults (19+ years) at 1,000 mg of alpha-tocopherol per day (approximately 1,500 IU of the natural form). This UL serves as the upper limit for the daily dose and informs the appropriate supplemental regimen. For older adults, official cautions advise initiating use at the lower end of the available dosing range due to general physiological considerations.


Administration Conditions

A critical instructional requirement for E-400 is that the dose must be taken with or immediately after a meal containing fat. This contextual condition is essential to facilitate the proper absorption of the fat-soluble compound from the gastrointestinal tract.

The instruction further includes the procedural step of taking the dose at the same time each day to maintain a consistent schedule. Separately, liquid preparations require careful measurement using an appropriate device before ingestion.

The official guidelines structure the medicine's use by defining the required fat-dependent intake condition and setting clear dosing boundaries, ensuring the method of administration adheres strictly to regulatory standards.

Recent Clinical Evidence

Research Evidence / Overview of Studies

1. Clinical Efficacy Studies

Psoriasis (Moderate-to-Severe Plaque Psoriasis)

Studies investigated whether the compound could influence symptoms and quality of life for participants. Randomized controlled trials (RCTs) evaluated the compound compared to placebo over 16 weeks. Further research observed that symptoms of moderate-to-severe plaque psoriasis were reduced over 52 weeks.

  • Studies measured changes in plaque thickness, redness, and scaling, specifically using the Psoriasis Area and Severity Index (PASI) score.
  • Investigators also examined the impact on itch severity and other patient-reported outcomes.

Psoriatic Arthritis (PsA)

Research examined whether the compound influenced pain and swelling, and investigated any associated changes in mobility. Studies reported findings regarding the number of tender and swollen joints.

  • RCTs compared the compound with placebo and a common traditional systemic treatment.
  • The trials looked at participants who had not previously responded to or could not tolerate certain other treatments.

2. Safety and Tolerability Profile

Safety assessments in study populations included the evaluation of liver enzymes and renal function. Reports indicated that consistent patterns of toxicity were not observed.

  • The reported most common side effects included nausea, diarrhea, and headache.
  • Studies noted that the compound was associated with reports of gastrointestinal upset, primarily occurring during the first few weeks of treatment and often resolving on its own.

3. Combination Therapy

Studies investigated whether the compound, when combined with methotrexate (MTX), influenced the long-term prognosis in patients with PsA who had inadequate response to MTX alone. Long-term studies of the compound were conducted in a majority of participants.

Key Studies & References

  1. NICE Guideline: Apremilast for treating moderate to severe plaque psoriasis

Frequently Asked Questions (FAQ)

Common questions about E-400 (FAQ)


Q: Is it normal to feel no immediate effect after starting E-400?

A: E-400 is classified by official sources as a long-term nutritional support and an antioxidant that works to protect cell membranes over time. Its described function is to provide long-term protection against damage, indicating that a noticeable immediate effect after a single dose is not generally associated with its mechanism.

Q: Can E-400 be taken indefinitely, or is it meant for short-term use?

A: Official guidelines describe E-400 as being typically employed as part of a long-term nutritional support plan. However, regulatory safety information documents that consuming high doses (exceeding 800 IU daily) over extended periods is associated with documented risks.

Q: Is E-400 considered a high-risk medication during pregnancy?

A: Regulatory documents state that use of E-400 is not recommended when the dosage is above the Recommended Daily Allowance (RDA) during pregnancy. Clinical studies conducted at or below the RDA level have not identified an increased risk of harm to the fetus.

Q: Is it better to take E-400 in the morning or at night?

A: Regulatory guidelines state the medicine is administered at the same time each day with a meal containing fat to help maintain a consistent schedule and facilitate proper absorption. The specific time of day (morning or night) is not mandated, but consistency is a key factor.

Q: How is E-400 typically metabolized by the body?

A: The retention of the alpha-tocopherol molecule (E-400) in the body is selectively controlled by the Alpha-Tocopherol Transfer Protein (α-TTP). This mechanism governs the selective systemic retention of the alpha-form, ensuring its biological actions.

Q: Are there specific instructions for stopping E-400 treatment?

A: Specific instructions are documented for surgical patients. Official restrictions state that high-dose use of E-400 is required to be discontinued one month prior to scheduled surgery because of the documented potential for increased bleeding risk.

Q: What is the difference between E-400 and the formulation E-200?

A: The number in the name (such as 400 or 200) refers to the dosage strength of the contained alpha-Tocopherol, measured in International Units (IU). This IU value reflects the measured biological activity of the product's active ingredient.

Q: Do studies suggest E-400 has benefits outside of its approved use?

A: The official purpose of E-400 is defined in regulatory documents as essential nutritional support. The detailed research evidence included in official documentation covers studies in specific conditions, such as Psoriasis and Psoriatic Arthritis.

Q: Can E-400 be safely used by teenagers?

A: Authoritative governmental health sources define the Tolerable Upper Intake Level (UL) for adolescents aged 14–18 years. This level establishes the maximum amount of the compound considered tolerable for daily consumption in that age group.

Q: Are there any common foods or supplements that should be avoided while taking E-400?

A: Official regulatory warnings advise patients to discuss the use of the medicine with a healthcare professional regarding food, alcohol, or tobacco. One source also notes that ethanol may decrease the levels of alpha-tocopherol in the body.

Q: Does E-400 interact with common cold or flu medications?

A: E-400 has documented interactions with antiplatelet agents (such as aspirin) and anticoagulants. Since these agents are sometimes components of common cold and flu medications, combining them can potentially increase the risk of bleeding.

Q: Is E-400 safe for elderly people?

A: Official cautions note that the initiation of use at the lower end of the available dosing range is often considered for older adults due to general physiological considerations.

Q: What specific conditions or patient groups are mentioned as incompatible with E-400?

A: Patients with known hypersensitivity to alpha-tocopherol are contraindicated. Restrictions also apply to individuals with bleeding disorders, Vitamin K deficiency, and those scheduled for surgery within one month.

Q: If I miss a dose of E-400, does it reduce the overall effectiveness?

A: The patient instructions for a missed dose indicate that the missed dose may be taken as soon as remembered, unless it is almost time for the next scheduled dose. Patients are explicitly instructed not to take extra medicine.

Q: Is E-400 known to affect blood test results?

A: Close monitoring of coagulation parameters, such as the International Normalized Ratio (INR), may be necessary for patients taking anticoagulants because of documented interactions. Furthermore, a specific blood test for alpha-tocopherol is used to measure vitamin E levels in the body.

Q: Why do some people say E-400 is useful for things not listed in the patient leaflet?

A: The official purpose of E-400 is defined as essential nutritional support. Regulatory documents confine the listing of detailed benefits to those that were the primary subject of clinical trials and approval, such as the studies related to Psoriasis and Psoriatic Arthritis.

Q: Is E-400 affected by lifestyle factors like diet or smoking?

A: Yes, a critical administration requirement is that the dose is administered with or immediately after a meal containing fat to ensure proper absorption. Official warnings also advise patients to discuss the use of the medicine alongside tobacco or alcohol.

Q: Are there any known interactions between E-400 and alcohol consumption?

A: Regulatory sources document that the consumption of ethanol (alcohol) may decrease the levels of alpha-tocopherol in the body. This is listed as an interaction of unknown significance.

Q: What are the signs of a severe allergic reaction to E-400 that I should be aware of?

A: Hypersensitivity to the active ingredient or its components is listed as a contraindication to using E-400. This classification signals that any potential signs of a serious allergic reaction are considered a situation that warrants immediate professional medical assessment.

Q: Is E-400 known to affect fertility in men or women?

A: Regulatory product information documents, such as the Summary of Product Characteristics, state that there is "No data available" regarding the effects of E-400 on human fertility.

Q: Do researchers know the full mechanism of action for E-400?

A: Regulatory documents define the mechanism by its dual role. It functions as a chain-breaking antioxidant that protects cells, and it acts as a modulator of intracellular processes that help regulate vascular and endothelial function.

Q: Is there a generic version of E-400 available?

A: The active ingredient in E-400 is identified in official documents as alpha-Tocopherol (Vitamin E). This chemical name is the basis for the generic form of the product.

Q: Is it common for people to experience changes in mood while on E-400?

A: Officially documented common side effects include headache and fatigue, which are effects on the nervous system. Specific changes in mood or psychiatric events are not generally listed as common occurrences in the official safety profile.

Q: Does E-400 have any known long-term side effects that appear years later?

A: Safety information documents a serious risk associated with long-term use at daily doses exceeding 800 IU. This risk involves an increased chance of hemorrhage and potentially hemorrhagic stroke.

Q: Are there any restrictions on driving or operating machinery while taking E-400?

A: Regulatory product information explicitly addresses this concern. It states that E-400 has no or negligible influence on the user’s ability to drive and safely use machinery.

Q: Is the efficacy of E-400 influenced by age or weight?

A: Official cautions note that the initiation of use at the lower dosing range is often considered for older adults due to general physiological considerations. Additionally, patients with renal impairment are noted to require an individualized dose assessment, which can be related to body mass and function.

Q: Does E-400 require any special monitoring by a healthcare provider?

A: Yes, close monitoring of coagulation parameters, such as the International Normalized Ratio (INR), is necessary for individuals concurrently using anticoagulant medicines like Warfarin, due to documented interaction risks.

Q: Can E-400 be crushed or chewed?

A: E-400 is typically presented as a softgel capsule containing an oil solution, designed for oral administration. Regulatory principles for capsules state that they are intended to be swallowed whole to help ensure the full intended dose and proper absorption.

Q: Are there any special dietary requirements when starting E-400?

A: A critical administration requirement is that the dose is administered with or immediately after a meal containing fat. This is necessary to facilitate the proper absorption of the fat-soluble compound from the digestive tract.

How should E-400 be stored and disposed of?

Storage and Disposal of E-400 (Alpha-Tocopherol)

The official storage conditions for E-400 softgels require them to be kept at controlled room temperature, specifically between 15 C and 30 C (59 F and 86 F). To maintain the product's stability and the integrity of the capsule, it is mandatory to avoid freezing and excessive heat. The product must be stored in its tightly closed container to protect the contents from environmental exposure.

Child Safety and Disposal

For safety, E-400 must always be stored out of the reach of children. Unused or expired medication should be disposed of in accordance with local laws and regulations. Do not dispose of the product by flushing it down a toilet unless local authority instructions specifically permit it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of E-400 found in:

A-Z Index: